Gedatolisib Terminated Phase 2 Trials for Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia / Relapsed Acute Myelogenous Leukemia (AML) / de Novo Acute Myeloid Leukemia at Diagnostic Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02438761PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML)